https://www.selleckchem.com/products/fgf401.html
SIGNIFICANCE KRAS is the most frequently mutated oncogene. Here, we describe new preclinical models that mimic tissue-selective KRAS mutations and show that each mutation has distinct cellular consequences in vivo and carries differential sensitivity to targeted therapeutic agents.See related commentary by Kostyrko and Sweet-Cordero, p. 1626.This article is highlighted in the In This Issue feature, p. 1611. Alcohol-related vehicle crashes pose a significant challenge to public health in suburban communities. The Evesham Saving Lives prog
Like
Comment
Share
